Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Ahmet Okumus Cuts Some AVG Shares

AVG Technologies NV (NYSE:AVG)’s position in the equity portfolio of Okumus Fund Management, recently went down by about 3.3 million shares. In a filing with the Securities and Exchange Commission, the hedge fund managed by Ahmet Okumus disclosed ownership of slightly above 2.1 million shares. At the current price of AVG’s stock the value of Okumus’ stake in the company amounts to $54.5 million, while the stake represents slightly below 4% of the company.

AVG Technologies NV (NYSE:AVG)

Amsterdam-headquarted software company AVG Technologies is mostly known for its internet security and antivirus software under the AVG brand. The move made by Okumus comes only a couple of days before AVG Technologies’ shareholder meeting scheduled for September 24. One of the main points on the meeting’s agenda is the appointment of the company’s Management Board Member/Chief Executive Officer Gary Kovacs, who is the former CEO of Mozilla Corporation.

In addition to Okumus, we should mention some other hedge funds disclosed ownership of AVG Technologies last quarter. They are: Renaissance Technologies, founded by Jim Simons, which held 335,000 shares at the end of the second quarter. In the second and third places are John Thaler’s Jat Capital Management, with over 152,100 shares, and Robert B. Gillam’s Mckinley Capital Management.

Recommended Reading:

2 Billionaire Interviews You Need To Watch

Hedge Fund Advertising, Start Your Engines

Should Investors Follow Carl Icahn Into This Auto Supplier?

Disclosure: none

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!